--- title: "LIVZON PHARMA released its performance for the first three quarters, with a net profit attributable to the parent company of 1.754 billion yuan, an increase of 4.86% year-on-year" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/262386461.md" description: "According to the Zhitong Finance APP, LIVZON PHARMA released its performance for the first three quarters of 2025, with the group achieving operating revenue of 9.116 billion yuan, an increase of 0.38% year-on-year; net profit attributable to the company's shareholders was 1.754 billion yuan, an increase of 4.86% year-on-year; basic earnings per share were 1.96 yuan" datetime: "2025-10-23T09:08:07.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/262386461.md) - [en](https://longbridge.com/en/news/262386461.md) - [zh-HK](https://longbridge.com/zh-HK/news/262386461.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/262386461.md) | [English](https://longbridge.com/en/news/262386461.md) # LIVZON PHARMA released its performance for the first three quarters, with a net profit attributable to the parent company of 1.754 billion yuan, an increase of 4.86% year-on-year According to the Zhitong Finance APP, LIVZON PHARMA (01513) released its performance for the first three quarters of 2025, with the group achieving operating revenue of 9.116 billion yuan, an increase of 0.38% year-on-year; net profit attributable to shareholders of the company was 1.754 billion yuan, an increase of 4.86% year-on-year; basic earnings per share were 1.96 yuan ### 相關股票 - [LIVZON GROUP (000513.CN)](https://longbridge.com/zh-HK/quote/000513.CN.md) - [LIVZON PHARMA (01513.HK)](https://longbridge.com/zh-HK/quote/01513.HK.md) ## 相關資訊與研究 - [Korea Zinc sees 17%-19% profit margin from planned U.S. smelter - chairman](https://longbridge.com/zh-HK/news/278835976.md) - [Standard Chartered bought back total 916,173 shares for GBP15.5 mln on other exchanges on Mar 10, HKEX filing shows](https://longbridge.com/zh-HK/news/278705553.md) - [17:31 ET26Health Acquires Optimal Integrative Care, Expanding Access to Integrated Healthcare in Atlanta](https://longbridge.com/zh-HK/news/279095408.md) - [09:17 ETChartis names SAS a leader in AI Governance](https://longbridge.com/zh-HK/news/278892644.md) - [17:22 ETEatsbueno Announces Integrated AI-Driven Corporate Wellness Platform Designed for Global Enterprise Performance](https://longbridge.com/zh-HK/news/278946693.md)